NTO specialist in Cambe, Brazil

Novartis is committed to keep the environmental impact from waste at a minimum and follows a clear waste management strategy. The aim is to prevent, reduce, recycle or use waste as an energy source, before selecting safe disposal as an option. Waste prevention and reduction is always preferred to treatment, incineration or disposal. This helps ensure the overall environmental impact related to waste remains minimal, while energy use from waste is maximized. All Novartis sites report waste data on a quarterly basis and our waste contractors are routinely audited to help ensure our waste is properly managed.

We currently recycle approximately 80% of all non-hazardous waste and 50% of all hazardous waste and continue to maximize opportunities for reuse and recycling. We are also making progress toward eliminating single-use plastics in all our workplaces. We eliminated 17 single-use plastic types at 132 sites.


Eliminate polyvinyl chloride (PVC) in packaging and reduce waste disposal by half versus 2016 levels.¹


Be plastic neutral with all new products meeting sustainable design principles.

Material to be recycled

At the Novartis site in Cambe, Brazil, a unique recycling project using raw material from blister packaging could set a precedent across the company.

Lab equipment

Two projects, aiming to revolutionize early drug discovery, could also help reduce hazardous waste.

  1. From Novartis owned and operated sites. Defined as secondary and tertiary packaging; primary packaging when feasible